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Abstract 
Purpose: To investigate the impact of mitochondrial transcription factor A (TFAM), as a modulator of 
NF-κB, on proliferation of hypoxia-induced human retinal endothelial cell (HREC), and the probable 
mechanism.  
Methods: After exposure to hypoxia (1 % O2) for 5 days, cell proliferation and cell cycle of HREC were 
measured by MTT (3-（4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) assay and flow 
cytometry. Cell signaling and mitochondrial DNA (mtDNA) copies were determined using real-time 
polymerase chain reaction and Western blot. NF-κB activity was evaluated by luciferase assay. 
Results: TFAM expression decreased to 40 % in HREC under hypoxic condition (p < 0.05). MTT results 
revealed that TFAM facilitated HREC proliferation under hypoxia (p < 0.05). Moreover, flow cytometry 
demonstrated that TFAM promoted HREC proliferation by accelerating cell cycle (p < 0.05). Western 
blot and luciferase assay exhibited NF-κB activation in HREC after TFAM overexpression (p < 0.05). 
Finally, real-time PCR results showed that mtDNA and targeted genes of NF-κB were upregulated 3-fold 
in HREC after TFAM transfection under hypoxia (p < 0.05).  
Conclusion: These results indicate that NF-κB activated by TFAM protects against hypoxia-induced 
HREC injury by accelerating cell cycle. The ability of TFAM to enhance NF-κB signaling may be part of 
the mechanism of hypoxia-induced cell injury. Thus, upregulation of TFAM may help to relieve diabetic 
retinopathy.  
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Endothelium dysfunction plays an important role 
in the development of vascular complications in 
diabetes [1]. Premature death of the capillary 
components, including endothelial cell and 
pericytes, occurs during the vasodegenerative 
stage of diabetic retinopathy [2]. The injury of 
retinal microvessels induced by diabetes results 
in the features of diabetic retinopathy, such as 
blood-retinal barrier leakage, non-perfusion 
capillary formation, and neovascularization [3]. 
Hypoxia is an important factor for the 
pathogenesis of human retinal endothelial cell 
(HREC) injury, which may promote intraocular 
neovascularization via imbalancing angiogenic 
homeostasis under physiological conditions [4,5]. 
However, the precise mechanism by which 
hypoxia affects HREC proliferation still needs 
further elucidation.  
 
Retinal    mitochondria    are    compromised    in 
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diabetes, leading to mitochondrial DNA (mtDNA) 
damage [6]. As mtDNA is extremely important in 
the electron transport chain, it plays a critical role 
in regulating superoxide and apoptosis [7,8]. 
Mitochondrial transcription factor A (TFAM), as 
one of the key factors that binds to the regulatory 
area of mtDNA, activate the transcription of the 
target proteins of mtDNA [9].  
 
TFAM gene expression was found to be 
increased, while its protein level was unchanged 
in diabetic retina [10]. However, mitochondrial 
protein levels are reduced in diabetes. 
Mitochondrial dysfunctional and mtDNA damage 
are still not alleviated even after recovery of 
normal glycemic condition in diabetic rats [11]. 
Thus, it was postulated that TFAM may regulate 
metabolic disorder of retina through 
posttranscriptional modification. Its influence on 
cell proliferation under hypoxia condition also 
needs further investigation.  
 
NF-κB plays key roles in numerous cellular, even 
in physiological, and pathological processes, as 
a multi-faceted transcription factor. [12-14]. 
Traditionally, NF-κB is a central mediator in 
immune and inflammatory responses [14], and it 
also participates in the progression of cancer 
[15]. The anti-apoptotic and proliferative 
functions of NF-κB in parenchymal cells facilitate 
repair of organ [16], whereas it can accelerate 
inflammation in macrophages and other 
inflammatory cells [13,14]. In addition, NF-κB is 
involved in energy balance [17] and tissue 
homeostasis [18]. Although the functions of NF-
κB in inflammation and cancer have been widely 
explored [19], its potential role in diabetic 
retinopathy. Since diabetic retinopathy is 
significantly related to retinal endothelial cell 
injury, NF-κB may participate in regulating HREC 
proliferation and cell cycle in diabetic retinopathy, 
in which it has not been investigated the 
underlying function of NF-κB. Herein, we aimed 
to explore if TFAM regulate hypoxia induced 





Cell culture and hypoxia condition 
 
HREC was purchased from American Type 
Culture Collection (ATCC, USA). DMEM medium 
was used for maintaining the cells supplemented 
with 10 % fetal calf serum, streptomycin (0.1 
mg/mL) and penicillin (100 U/mL) at 5 % CO2 
and 37 °C. Normal incubators with 21 % O2 were 
applied as the normoxic condition. Incubators 
with 1 % O2, 5 % CO2, and 94 % N2 were used 
for hypoxic cultures.  
MTT assay 
 
The HREC were seeded in 96-well plate at 2 × 
103 cells/well. Cells were then transfected with by 
TRAM or TRAM siRNA for 24 h. During the last 4 
h of each day of culture, cells were treated with 
MTT (at 50 mg per well (Sigma, St. Louis, MO). 
The formazan was dissolved with dimethyl 
sulfoxide (DMSO) for 30 min and a microplate 
reader (Bio-tek, Winooski, VT) was used to 
measure the absorbance at 450 nm. 
 
Cell cycle analysis 
 
HREC cells were collected and washed three 
times with PBS. The cells were fixed in 70 % 
precooled ethanol (1 mL) at 4 °C overnight. Next, 
the cells were washed with PBS and incubated in 
RNase (100 µg/mL) at 37 °C for 0.5 h. After 
staining with PI (50 µg/mL ) at 4 °C  for 30 min in 
the dark, flow cytometry was used to analyze  the 
cell cycle  at 488 nm. The primary result was 
analyzed with FlowJo software to acquire the 
hypodiploid peak, so as to calculate the cell ratio 
in G0/G1 phase, S phase, and G2/M phase, 





TaKaRa MiniBEST universal RNA Extraction Kit 
(Takara, Japan) was used to extracted the total 
RNA. RNA was eluted in 50 mL of RNase-free 
water and preserved at -70 °C. To analyze gene 
expression, real-time PCR mixture system 
containing primers, cDNA templates, and SYBR 
Green qPCR Master Mix were reacted using 
real-time PCR according to standard methods. 
Fold changes in gene expression were 
calculated upon 2-△△Ct method with as an internal 
control of GAPDH.  
 
Determination of mitochondrial DNA (mtDNA) 
copy number 
 
Quantification of mitochondrial DNA was 
operating as a previously reported method with 
minor modifications [20]. The PAGE-purified 
synthetic oligonucleotide standard (Integrated 
DNA Technologies, Coralville, IA) was diluted 
using TE-4 to generate standards. The 
amplification reactions consisted template DNA 
(1 μL) at a final volume of 25 μL. All qPCR 
experiments consisted minimally of each 
quantification standard in duplicate, a TE-4 no-
template control, and an HL-60 DNA-positive 
control.  
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Western blot analysis 
 
HREC cells were lysed with loading lysis buffer 
that was diluted from 5 × loading lysis buffer (2.5 
mL Tris–HCl at 0.5 M, 0.39 g dithiothreitol, 0.5 g 
sodium dodecyl sulfate, 0.025 g bromophenol 
blue, and 2.5 mL glycerin). Equal amount of 
protein was transferred to the polyvinylidene 
fluoride (PVDF) membrane. Next, the membrane 
was blocked with skimmed milk and further 
incubated in primary antibodies at 4 oC for 1 h. 
After incubation with horseradish peroxidase 
(HRP)-conjugated secondary antibodies, in the 
binding signals were visualized with enhanced 





Cells were transfected by Lipofectamine 2000 
transfection reagent (Invitrogen) according to the 
manual. For the gene expression analyses, cells 
were transfected with plasmid DNA (1 μg /well); 
TFAM (50 ng) or TFAM siRNA, pDUO-hMD-
2/CD14 (300 ng) adjusted with pcDNA3.1 to 1 
μg. The total plasmid load was adjusted to 1 μg 




Cells were seeded in 24-well plate. then 
transfected with TFAM plasmid or siRNA.48 h 
later, the cells were transfectedwith 0.5 µg NF-κB 
reporter (GeneCopoeia, China) and 10 ng pRL-
TK plasmids (Promega, WI) using EndoFectin™-
Plus. These were performed according to the 
dual-luciferase assay specifications (Promega, 
US) using the Lucetta™ Luminometer (Lonza, 
Swiss). The transfection efficiency was 
measured by the normalized activity of firefly 
luciferase to the. All of the experiment were 




All data analyses were carried out with SPSS 
18.0 software. The data are presented as mean 
± standard (SD) and compared by t-test or one-
way ANOVA. P < 0.05 was considered 




Down-regulation of TFAM expression in 
hypoxia treated HREC 
 
To compare the mRNA expression of TFAM in 
HREC cells from the normal culture and hypoxic 
culture, cells were subjected to real-time PCR. 
The results showed that TFAM mRNA 
significantly increased in the hypoxic group 
(Figure 1A). Furthermore, it was found that 
TFAM mRNA level gradually reduced in HREC 
under hypoxic environment following time 
extension (Figure 1B). 
 
TFAM transfection enhanced HREC 
proliferation 
 
Since TFAM was downregulated in HREC under 
hypoxia environment, we proposed that TFAM 
was involved in regulating HREC behavior. 
HREC cells were transfected with TFAM plasmid 
and incubated under hypoxia environment. The 
result of Real-time PCR showed that TFAM 
mRNA was significantly overexpressed in HREC 
cells after TFAM transfection (Figure 2A). MTT 
assay revealed that TFAM upregulation 
enhanced HREC cell proliferation under hypoxia 
condition (Figure 2B). 
 
 
Figure 1: TFAM downregulated in HREC under hypoxia. (A) TFAM mRNA expression in HREC under hypoxic 
and normoxic culture. (B) TFAM mRNA expression in HREC cultured in hypoxia at different times; *p < 0.05, 
compared with control 
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Figure 2: TFAM facilitated HREC cell proliferation and cell cycle. (A) TFAM mRNA expression in HREC after 
TFAM transfection. (B) HREC cell proliferation detected with MTT assay after TFAM transfection. (C) HREC cell 
cycle determined by flow cytometry after TFAM transfection. (D) Cell proliferation and cell cycle related gene 
expressions in HREC tested by real-time PCR after TFAM transfection; *p < 0.05, compared with control 
 
Flow cytometry demonstrated that TFAM 
transfection apparently accelerated HREC cell 
cycle compared with control (Figure 2C). Also, 
cell cycle related molecules Cyclin D1 and Cyclin 
E were found to be markedly increased, while 
apoptotic factor Bim decreased in HREC after 
TFAM transfection. 
 
TFAM inhibition blocked HREC proliferation 
 
To further analyze the effect of TFAM in HREC 
cell proliferation and cell cycle, we adopted 
TFAM siRNA to downregulate TFAM level. It was 
found that TFAM mRNA was significantly 
reduced in HREC transfected by TFAM siRNA 
(Figure 3A). Moreover, HREC cell proliferation 
was inhibited by TFAM siRNA under hypoxic 
condition (Figure 3B). HREC cell cycle was 
blocked in G0/G1 phase by TFAM interference in 
hypoxia group (Figure 3C). Cyclin D1 and Cyclin 
E were markedly downregulated, whereas Bim 
was enhanced in HREC after TFAM interference 
(Figure 3D). 
 
TFAM regulated NF-κB signaling in HREC 
under hypoxia condition 
 
To investigate the specific mechanism of TFAM 
in regulating HREC cell proliferation, real-time 
PCR results showed that mtDNA copy number 
was significantly elevated in HREC transfected 
by TFAM, while TFAM siRNA showed the 
opposite effect (Figure 4A). Western blot 
demonstrated that p65 protein level in HREC 
nucleus was enhanced in the TFAM transfection 
group compared with control. TFAM siRNA 
apparently suppressed p65 protein expression in 
HREC nucleus (Figure 4B). Luciferase assay 
showed that the activity of NF-κB was activated 
in HREC transfected by TFAM, suggesting the 
regulatory role of TFAM on NF-κB signaling 
pathway (Figure 4C). Multiple target genes of 
NF-κB signaling pathway, including MYC, FLIP, 
TNF, Bmil, and IL-8 were upregulated by TFAM, 
while they declined in HREC treated with TFAM 




Retinal endothelial cell proliferation suppression 
is considered to be the hallmark of diabetic 
retinopathy, while mitochondria insufficiency 
plays a key role in facilitating retinal cell 
apoptosis [21]. In this study, we identified the 
protective role of TFAM in diabetic retinopathy by 
promoting HREC cell proliferation and cell cycle 
under hypoxic condition. We also observed that 
part of the acceleration effects of TFAM on 
HREC cell proliferation is mediated by regulating 
NF-κB signaling pathway. 
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Figure 3: TFAM siRNA inhibited HREC cell proliferation and cell cycle. (A) TFAM mRNA expression in HREC 
after TFAM siRNA transfection. (B) HREC cell proliferation detected by MTT assay after TFAM siRNA 
transfection. (C) HREC cell cycle determined by flow cytometry after TFAM siRNA transfection. (D) Cell 
proliferation and cell cycle related gene expressions in HREC tested by real-time PCR after TFAM siRNA 
transfection; *p < 0.05, compared with control 
 
 
Figure 4: TFAM regulated NF-κB signaling pathway in HREC. (A) mtDNA copy number in HREC assessed by 
real-time PCR. (B) Cellular nuclear p65 protein expression in HREC determined by Western blot. (C) NF-κB 
activity in HREC evaluated by luciferase assay. (D) Target gene expressions of NF-κB signaling pathway in 
HREC detected by real-time PCR; *p < 0.05, compared with control 
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Mitochondria are the initial consumers of oxygen. 
A variety of products of mitochondria have been 
shown to mediate the activity of HIF prolyl 
hydroxylases, such as TCA cycle intermediates, 
ROS, and oxygen consumption [22]. The 
importance of mitochondria as regulators of HIF 
signaling pathway, which is critical in hypoxia 
homeostasis, has been highly confirmed as 
numerous effective inhibitors of HIF activation 
were verified to be mitochondrial inhibitors [23]. 
By comparing HREC under normoxic and 
hypoxic conditions, we discovered that TFAM 
mRNA level was higher in hypoxic HREC than 
normal control. Moreover, it was also revealed 
that TFAM expression was gradually reduced in 
HREC stimulated by hypoxia following elongation 
of incubation time. Thus, we proposed that TFAM 
may be involved in the pathogenesis of diabetic 
retinopathy.  
 
As a transcription factor for mitochondrial DNA, 
TFAM is required for replication and transcription 
of mtDNA. It has reported that TFAM is 
participate in the regulation of cell survival, 
proliferation and migration. For example, the 
proliferation of vascular smooth muscle cell is 
dependent on the upregulation of TFAM 
expression in injured rat carotid artery [24]. It has 
been proved that TFAM regulates p21 
(WAF1/CIP1), which is a key regulator of cell 
cycle progression, since knockdown of TFAM 
expression would induce p21-dependent G1 cell 
cycle arrest [25]. Moreover, TFAM is participate 
in the development and progression of malignant 
tumors. In microsatellite-unstable colorectal 
cancer, frequent truncating mutation of TFAM 
induced depletion of mtDNA and apoptotic 
resistance [26]. However, the role of TFAM in 
HREC under hypoxic condition remains 
uncovered. In this study, we evaluated the 
impact of TFAM using MTT assay, flow 
cytometry, and real-time PCR. The results 
showed that TFAM overexpression promoted cell 
cycle and proliferation. On the contrary, TFAM 
siRNA led to cell cycle blockage and proliferation 
inhibition under hypoxia. These results supported 
the hypothesis that TFAM participates in cell 
proliferation in HREC. 
 
We further identified the potential targets of 
TFAM, which we further verified by Western blot, 
luciferase assay, and real-time PCR. The results 
indicated that TFAM promoted NF-κB 
translocation into nucleus in HREC under 
hypoxic condition. Luciferase assay suggested 
that TFAM effectively enhanced the activity of 
NF-κB, which further verified the role of TFAM on 
NF-κB in hypoxic environment. Real-time PCR 
demonstrated that several target genes of NF-κB 
signaling pathway were upregulated by TFAM 
transfection in HREC, confirming the promoting 
effect of TFAM on NF-κB signaling pathway. NF-
κB transcription factor family regulates a large 
amount of genes involved in cell function and 
inflammation. NF-κB family proteins have been 
detected in diabetic retinopathy and participate in 
ganglion cell death, formation of epiretinal 
membranes, and angiogenesis [27-29]. 
Furthermore, TFAM was found to be involved in 
the protective role of astrocytes in protecting 
neurons through NF-κB signaling pathway, 





The findings of the study show that TFAM is 
downregulated in HREC under hypoxia. This 
mitochondrial modulator promotes NF-κB 
signaling pathway. Aberrant overexpression of 
TFAM in diabetic retinopathy causes increased 
NF-κB signaling pathway in HREC. This 
abnormal signaling further allows cells to 
promote proliferation and cell cycle, leading to 
the protection of retinal endothelial cells in 
diabetic retinopathy. These results provide new 
insight into diabetic retinopathy and a potential 
choice for diabetic retinopathy therapy, as TFAM 
activity clearly affects the critical mechanism in 
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